USA: No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD Patients

There is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published online May 18 in Clinical Gastroenterology and Hepatology.

Steven H. Itzkowitz, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues followed 305 patients with IBD and confirmed index cancer prior to enrollment. Index cancers were solid organ, dermatologic, gastrointestinal, and hematologic (46, 32, 13, and 9 percent, respectively).

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=NTdjMmQ3MDItZDYwNi00MTMzLTgxNTYtZTFmMTY4NzEzYWFk&client=Nw%3D%3D&section=undefined